FDA 483 - Valdepharm - April 27, 2015

Valdepharm, a sterile drug manufacturer in Val de Reuil, France, was inspected by the FDA, revealing deficiencies in its aseptic processing areas. The firm's air supply and air flow visualization studies were found to be inadequate. These issues indicate potential risks to maintaining sterile conditions during drug manufacturing.